EGFR and head and neck squamous cell carcinoma: Some authors have proposed that the inferior survival outcomes in patients with HPV associated oropharyngeal HNSCC who received concurrent chemoradiation with cetuximab instead of cisplatin might be related to differences in EGFR expression and HPV status.